Scientists at Oxford University are rapidly developing a new vaccine for the rare Bundibugyo Ebola virus, with the potential for clinical trials to begin in two to three months, amidst an ongoing outbreak in the Democratic Republic of Congo that has resulted in 750 suspected cases and 177 deaths. #EbolaVaccine #PublicHealth #VaccineDevelopment
RT @NicHulscher: Just 4 months before the Bundibugyo Ebola outbreak, Bill Gates’ vaccine enterprise CEPI gave Moderna and Oxford $26.7 MILL… #Ebola #Vaccines #PublicHealth #UG
The World Health Organization (WHO) has warned that it could take up to nine months for a vaccine to be developed against the Bundibugyo species of Ebola, as the death toll rises amidst a confirmed 51 cases in the Democratic Republic of Congo and neighboring Uganda, highlighting overwhelming healthcare challenges in the region. #EbolaOutbreak #WHO #VaccineDevelopment
(TR) Geert Vanden Bossche, one of the greatest virologists in the world, reveals to us that he was there on site when the WHO launched clinical trials for Merck's Ebola vaccine. He concludes that the Ebola vaccine was "100% effective." Geert tells Steve Kirsch that
RT @StanfordMed: Stanford Medicine researchers and their colleagues invented a new vaccine that shows potential to protect against respirat… #Vaccine #StanfordMedicine #PublicHealth #Thetweetdoesnotmentionanyspecificcountries.Therefore #therearenocountrycodestoreturn.
In 1982, Jonas Salk discussed his revolutionary discovery of the polio vaccine, which saved countless lives, emphasizing that he refused to profit from it, leading an American journalist to describe the announcement in April 1955 as one of humanity's most enlightening moments. #Vaccines #Polio #MedicalInnovation #US
In 1982, Jonas Salk spoke to the BBC about his revolutionary discovery of the polio vaccine, which saved countless lives, yet he refused to profit from his invention, leading an American journalist to describe the announcement in April 1955 as one of the brightest pieces of news in human history. #Vaccines #PublicHealth #Innovation #US
RT @USW_PR_HONTata: Today, we are sharing the story of another resilient warrior who was negatively impacted by the COVID-19 vaccine mandat… #COVID19 #VaccineMandate #Resilience #US
RT @Suzierizzo1: This pregnant woman went to the pharmacy to get her vaccines that she was told to get by her OBGYN & this Antivaxxer start… #VaccinesWork #PublicHealth #Antivaxxers #Therearenospecificcountriesmentionedinthetweetprovided.
Nancy J. Cox, a renowned expert and leader of the influenza program at the C.D.C. for nearly 40 years, passed away at 77 due to glioblastoma, leaving behind a legacy of building a global network for flu research and prevention amid the ever-evolving challenges posed by influenza viruses. #Influenza #PublicHealth #VaccineResearch #US
Nancy J. Cox, the longtime leader of the influenza division at the C.D.C. who created a vital global network for flu forecasting and prevention, passed away on April 24 at 77 due to glioblastoma, leaving a legacy as one of the world's foremost flu experts. #Influenza #PublicHealth #VaccineResearch #US
Nancy J. Cox, the longtime leader of the C.D.C.'s influenza division who built a global network for flu research and prevention, passed away at 77 from glioblastoma, leaving behind a legacy as a leading expert in combating ever-evolving influenza viruses. #Influenza #PublicHealth #VaccineDevelopment #US
Researchers are developing a new mRNA vaccine for the hantavirus strain responsible for a recent outbreak on a cruise ship, while emphasizing that early treatment improves survival and stressing that there is no immediate need for panic as the disease is rare and not easily transmissible. #Hantavirus #VaccineDevelopment #PublicHealth #UK #NL
Researchers at the University of Bath are developing a new mRNA vaccine for the Hantaan strain of hantavirus, prompted by a recent outbreak of the Andes strain on a cruise ship, though they remain cautious about its effectiveness against the latter while highlighting the need for early medical support in outbreaks of this rarely transmitted virus. #VaccineResearch #Hantavirus #PandemicPreparedness #NL #GB
Researchers at the University of Bath are developing a new mRNA vaccine for the hantavirus strain Hantaan, spurred by a recent deadly outbreak of the Andes virus on a cruise ship, although uncertainty remains about its effectiveness against the latter strain and the outbreak is not expected to lead to a broader pandemic. #Vaccines #Hantavirus #PublicHealth #NL #GB
Researchers at the University of Bath are developing a promising new mRNA vaccine for hantavirus, prompted by a recent deadly outbreak of the Andes virus on a cruise ship, although it remains uncertain if the vaccine will be effective against this specific strain. #Vaccines #Hantavirus #PandemicPrevention #NL #UK
(TR) HISTORICAL: The Court of Appeal of Turin recognizes the Pfizer vaccine as responsible for serious neurological damage.
Researchers are developing a new mRNA vaccine for hantavirus, specifically targeting the Hantaan strain, in response to a deadly outbreak on the MV Hondius cruise ship caused by the Andes virus, highlighting concerns about the potential for emerging viral threats to trigger future pandemics. #Hantavirus #VaccineDevelopment #PublicHealth #UK #NL
Researchers are developing a new mRNA vaccine for the Andes virus strain of hantavirus following a deadly outbreak on a cruise ship, with promising early results from animal tests on a vaccine for a different strain, though its effectiveness against the Andes virus remains uncertain. #VaccineDevelopment #Hantavirus #PublicHealth #NL #GB
Team Europe is already a major global health investor, €6 billion mobilized in the current budget cycle. GHRI strengthens our investment where it counts: stronger health systems, local production of vaccines and medicines, and faster coordinated responses to outbreaks. https://t.co/g5Ng6pSyou #GlobalHealth #HealthInvestment #VaccineProduction #EU
